I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| pericyte | 9 studies | 22% ± 4% | |
| fibroblast | 8 studies | 21% ± 3% | |
| smooth muscle cell | 8 studies | 23% ± 3% | |
| type I pneumocyte | 7 studies | 22% ± 6% | |
| endothelial cell | 6 studies | 24% ± 6% | |
| adipocyte | 6 studies | 24% ± 7% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 19% ± 2% | |
| ciliated cell | 5 studies | 28% ± 9% | |
| renal alpha-intercalated cell | 4 studies | 28% ± 3% | |
| ionocyte | 3 studies | 25% ± 3% | |
| epithelial cell | 3 studies | 30% ± 9% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 17% ± 1% | |
| natural killer cell | 3 studies | 17% ± 2% | |
| muscle cell | 3 studies | 19% ± 3% | |
| GABAergic neuron | 3 studies | 43% ± 9% | |
| glutamatergic neuron | 3 studies | 49% ± 11% | |
| astrocyte | 3 studies | 27% ± 2% |
